title: Shedding light on testicular cancer.
abstract: Testicular cancer, though generally uncommon, is the most common cancer NPs will see in young men. Advances in surgery, radiation, and cisplatin-based chemotherapy, have made testicular cancer a "model" for a curable cancer. Survivors will likely live many years, but will require lifelong follow-up for possible recurrence and long-term treatment sequelae.
authors.affiliation: Division of Hematology/Oncology, University of Pennsylvania Health System, Philadelphia, PA, USA.
authors.forename: Barbara H
authors.initials: BH
authors.lastname: Zoltick
mesh_terms: D000293:Adolescent; D000328:Adult; D018237:Germinoma / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D012307:Risk Factors; D016353:Self-Examination / Q000379:methods; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D016896:Treatment Outcome; D057832:Watchful Waiting; D055815:Young Adult